New oncolytic virus shows improved effectiveness in preclinical testing

ScienceDaily (Oct. 27, 2011) — A new fourth-generation oncolytic virus designed to both kill cancer cells and inhibit blood-vessel growth has shown greater effectiveness than earlier versions when tested in animal models of human brain cancer.Researchers at the Ohio State University Comprehensive Cancer Center -- Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC -- James) are developing the oncolytic virus as a treatment for glioblastoma, the most common and deadly...

Read More